Another biotech buy for Roche
After making a $43.7 billion offer linkurl:yesterday;https://www.the-scientist.com/blog/display/54841/ (July 21) to buy the 44% of Genentech stock it didn't already own, the Swiss pharmaceutical company announced another biotech purchase today. Roche will acquire linkurl:Mirus Bio Corporation;https://www.mirusbio.com/ for $125 million. Roche's half-year financial linkurl:results,;https://www.roche.com/home/figures/fig_halfyearrep_2008.htm released on Monday but eclipsed by the Genentech offer,
Written byMegan Scudellari
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred Google source to see more of our trusted coverage.
Meet the Author
- This person does not yet have a bio.View Full Profile
